From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
This report summarises the surveillance results for Neisseria gonorrhoeae antimicrobial susceptibility in the EU/EEA. In 2012, 20 EU/EEA Member States participated in Euro-GASP.
Monitoring and responding to HIV and hepatitis C among people who inject drugs is the focus of two new reports from the EU drugs agencies EMCDDA and ECDC.
This report presents the results of the fourth round of the VTEC external quality assessment scheme for the typing of verocytotoxin-producing E. coli (VTEC).
This report presents the results of the third round of the VTEC external quality assessment scheme for the typing of verocytotoxin-producing E. coli (VTEC).
This survey was designed to collect information on the laboratory diagnosis of gonorrhoea, chlamydia and syphilis; clinical reporting; laboratory capacity for testing; laboratory accreditation and external quality assessment (EQA); training; reporting and laboratory systems.
This report presents the results from the 2011 gonococcal antimicrobial susceptibility surveillance programme (Euro-GASP) and a summary of the second distribution from the 2011 external quality assurance (EQA) scheme.